ID   SO1A5_RAT               Reviewed;         670 AA.
AC   O88397; Q9EQR8;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   10-JAN-2003, sequence version 2.
DT   29-MAY-2024, entry version 160.
DE   RecName: Full=Solute carrier organic anion transporter family member 1A5;
DE   AltName: Full=Organic anion-transporting polypeptide 3;
DE            Short=OATP-3;
DE   AltName: Full=Sodium-independent organic anion transporter 3;
DE   AltName: Full=Solute carrier family 21 member 7;
GN   Name=Slco1a5; Synonyms=Oatp1a5, Oatp3, Slc21a7, Slco1a2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   TRANSPORTER ACTIVITY, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9712861; DOI=10.1074/jbc.273.35.22395;
RA   Abe T., Kakyo M., Sakagami H., Tokui T., Nishio T., Tanemoto M., Nomura H.,
RA   Hebert S.C., Matsuno S., Kondo H., Yawo H.;
RT   "Molecular characterization and tissue distribution of a new organic anion
RT   transporter subtype (oatp3) that transports thyroid hormones and
RT   taurocholate and comparison with oatp2.";
RL   J. Biol. Chem. 273:22395-22401(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   TRANSPORTER ACTIVITY, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Ileum;
RX   PubMed=11093941; DOI=10.1152/ajpgi.2000.279.6.g1188;
RA   Walters H.C., Craddock A.L., Fusegawa H., Willingham M.C., Dawson P.A.;
RT   "Expression, transport properties, and chromosomal location of organic
RT   anion transporter subtype 3.";
RL   Am. J. Physiol. 279:G1188-G1200(2000).
RN   [3]
RP   FUNCTION, TRANSPORTER ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND DOMAIN.
RX   PubMed=19129463; DOI=10.1152/ajpcell.00436.2008;
RA   Leuthold S., Hagenbuch B., Mohebbi N., Wagner C.A., Meier P.J., Stieger B.;
RT   "Mechanisms of pH-gradient driven transport mediated by organic anion
RT   polypeptide transporters.";
RL   Am. J. Physiol. 296:C570-C582(2009).
CC   -!- FUNCTION: Na(+)-independent transporter that mediates the cellular
CC       uptake of a broad range of organic anions such as the endogenous bile
CC       salts cholate and deoxycholate, either in their unconjugated or
CC       conjugated forms (taurocholate and glycocholate), estrone 3-sulfate and
CC       prostaglandin E2, at the plasma membrane (PubMed:11093941,
CC       PubMed:19129463, PubMed:9712861). Responsible for intestinal absorption
CC       of bile acids (PubMed:11093941). Capable of thyroid hormone transport
CC       (both T3 or 3,3',5'-triiodo-L-thyronine, and T4 or L-tyroxine)
CC       (PubMed:19129463, PubMed:9712861). Plays roles in blood-brain and
CC       -cerebrospinal fluid barrier transport of organic anions and signal
CC       mediators, and in hormone uptake by neural cells (By similarity). May
CC       also play a role in the reuptake of neuropeptides such as substance
CC       P/TAC1 and vasoactive intestinal peptide/VIP released from retinal
CC       neurons (By similarity). Shows a pH-sensitive substrate specificity
CC       which may be ascribed to the protonation state of the binding site and
CC       leads to a stimulation of substrate transport in an acidic
CC       microenvironment (PubMed:19129463). Hydrogencarbonate/HCO3(-) acts as
CC       the probable counteranion that exchanges for organic anions
CC       (PubMed:19129463). May contribute to regulate the transport of organic
CC       compounds in testis across the blood-testis-barrier (By similarity).
CC       {ECO:0000250|UniProtKB:P46721, ECO:0000250|UniProtKB:Q91YY5,
CC       ECO:0000269|PubMed:11093941, ECO:0000269|PubMed:19129463,
CC       ECO:0000269|PubMed:9712861}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=taurocholate(out) = taurocholate(in); Xref=Rhea:RHEA:71703,
CC         ChEBI:CHEBI:36257; Evidence={ECO:0000269|PubMed:11093941,
CC         ECO:0000269|PubMed:9712861, ECO:0000305|PubMed:19129463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycocholate(out) = glycocholate(in); Xref=Rhea:RHEA:71851,
CC         ChEBI:CHEBI:29746; Evidence={ECO:0000269|PubMed:11093941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=taurochenodeoxycholate(out) = taurochenodeoxycholate(in);
CC         Xref=Rhea:RHEA:71855, ChEBI:CHEBI:9407;
CC         Evidence={ECO:0000269|PubMed:11093941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=tauroursodeoxycholate(out) = tauroursodeoxycholate(in);
CC         Xref=Rhea:RHEA:71843, ChEBI:CHEBI:132028;
CC         Evidence={ECO:0000269|PubMed:11093941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3,3',5'-triiodo-L-thyronine(out) = 3,3',5'-triiodo-L-
CC         thyronine(in); Xref=Rhea:RHEA:71815, ChEBI:CHEBI:57261;
CC         Evidence={ECO:0000269|PubMed:9712861};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-thyroxine(out) = L-thyroxine(in); Xref=Rhea:RHEA:71819,
CC         ChEBI:CHEBI:58448; Evidence={ECO:0000269|PubMed:9712861,
CC         ECO:0000305|PubMed:19129463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=taurodeoxycholate(out) = taurodeoxycholate(in);
CC         Xref=Rhea:RHEA:71863, ChEBI:CHEBI:36261;
CC         Evidence={ECO:0000269|PubMed:11093941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycodeoxycholate(out) = glycodeoxycholate(in);
CC         Xref=Rhea:RHEA:71867, ChEBI:CHEBI:82982;
CC         Evidence={ECO:0000269|PubMed:11093941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycochenodeoxycholate(out) = glycochenodeoxycholate(in);
CC         Xref=Rhea:RHEA:71859, ChEBI:CHEBI:36252;
CC         Evidence={ECO:0000269|PubMed:11093941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycoursodeoxycholate(out) = glycoursodeoxycholate(in);
CC         Xref=Rhea:RHEA:71847, ChEBI:CHEBI:132030;
CC         Evidence={ECO:0000269|PubMed:11093941};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=estrone 3-sulfate(out) = estrone 3-sulfate(in);
CC         Xref=Rhea:RHEA:71835, ChEBI:CHEBI:60050;
CC         Evidence={ECO:0000305|PubMed:19129463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=prostaglandin E2(out) = prostaglandin E2(in);
CC         Xref=Rhea:RHEA:50984, ChEBI:CHEBI:606564;
CC         Evidence={ECO:0000305|PubMed:19129463};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=substance P(out) = substance P(in); Xref=Rhea:RHEA:74367,
CC         ChEBI:CHEBI:190692; Evidence={ECO:0000250|UniProtKB:P46721};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=17.99 uM for taurocholate {ECO:0000269|PubMed:9712861};
CC         KM=20.9 uM for taurocholate {ECO:0000269|PubMed:11093941};
CC         KM=4.93 uM for L-thyroxine {ECO:0000269|PubMed:9712861};
CC         KM=7.33 uM for 3,3',5'-triiodo-L-thyronine
CC         {ECO:0000269|PubMed:9712861};
CC         KM=8.8 uM for cholate {ECO:0000269|PubMed:11093941};
CC         KM=15.4 uM for glycocholate {ECO:0000269|PubMed:11093941};
CC         KM=5.8 uM for taurodeoxycholate {ECO:0000269|PubMed:11093941};
CC         KM=4.3 uM for glycodeoxycholate {ECO:0000269|PubMed:11093941};
CC         KM=7.0 uM for taurochenodeoxycholate {ECO:0000269|PubMed:11093941};
CC         KM=6.6 uM for tauroursodeoxycholate {ECO:0000269|PubMed:11093941};
CC         KM=5.6 uM for glycochenodeoxycholate {ECO:0000269|PubMed:11093941};
CC         KM=5.3 uM for glycoursodeoxycholate {ECO:0000269|PubMed:11093941};
CC         KM=83.5 uM for estrone 3-sulfate (at pH 6.5)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=177 uM for estrone 3-sulfate (at pH 8.0)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=8.5 uM for taurocholate (at pH 6.5) {ECO:0000269|PubMed:19129463};
CC         KM=18.2 uM for taurocholate (at pH 8.0)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=56.8 uM for prostaglandin E2 (at pH 6.5)
CC         {ECO:0000269|PubMed:19129463};
CC         KM=108 uM for prostaglandin E2 (at pH 8.0)
CC         {ECO:0000269|PubMed:19129463};
CC         Vmax=38.7 pmol/min/mg protein for cholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=110.6 pmol/min/mg protein for taurocholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=56.7 pmol/min/mg protein for taurodeoxycholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=65.5 pmol/min/mg protein for glycodeoxycholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=106.7 pmol/min/mg protein for taurochenodeoxycholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=120.2 pmol/min/mg protein for glycochenodeoxycholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=43.6 pmol/min/mg protein for tauroursodeoxycholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=44.2 pmol/min/mg protein for glycoursodeoxycholate
CC         {ECO:0000269|PubMed:11093941};
CC         Vmax=383 pmol/min/mg enzyme with estrone 3-sulfate as substrate (at
CC         pH 6.5) {ECO:0000269|PubMed:19129463};
CC         Vmax=453 pmol/min/mg enzyme with estrone 3-sulfate as substrate (at
CC         pH 8.0) {ECO:0000269|PubMed:19129463};
CC         Vmax=55.1 pmol/min/mg enzyme with taurocholate as substrate (at pH
CC         6.5) {ECO:0000269|PubMed:19129463};
CC         Vmax=46.6 pmol/min/mg enzyme with taurocholate as substrate (at pH
CC         8.0) {ECO:0000269|PubMed:19129463};
CC         Vmax=85.1 pmol/min/mg enzyme with prostaglandin E2 as substrate (at
CC         pH 6.5) {ECO:0000269|PubMed:19129463};
CC         Vmax=98.2 pmol/min/mg enzyme with prostaglandin E2 as substrate (at
CC         pH 8.0) {ECO:0000269|PubMed:19129463};
CC       pH dependence:
CC         Optimum pH is 6.5 with estrone 3-sulfate, taurocholate, prostaglandin
CC         E2 and L-thyroxine (T4) as substrates. {ECO:0000269|PubMed:19129463};
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P46721};
CC       Multi-pass membrane protein {ECO:0000305}. Basal cell membrane
CC       {ECO:0000250|UniProtKB:P46721}; Multi-pass membrane protein
CC       {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the kidney, moderately abundant
CC       in the retina, and even lower in the liver (PubMed:9712861). Expressed
CC       (at protein level) in the small intestine (PubMed:11093941). Expressed
CC       at lower levels in brain,lung, and retina (PubMed:11093941).
CC       {ECO:0000269|PubMed:11093941, ECO:0000269|PubMed:9712861}.
CC   -!- DOMAIN: A conserved histidine residue in the third TMD (His-107) may
CC       play an essential role in the pH sensitivity of SLCO1A5/OATP1A5-
CC       mediated substrate transport. {ECO:0000305|PubMed:19129463}.
CC   -!- SIMILARITY: Belongs to the organo anion transporter (TC 2.A.60) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF041105; AAC32804.1; -; mRNA.
DR   EMBL; AF083469; AAG36719.1; -; mRNA.
DR   RefSeq; NP_110465.1; NM_030838.1.
DR   RefSeq; XP_006237704.1; XM_006237642.2.
DR   RefSeq; XP_006237705.1; XM_006237643.2.
DR   RefSeq; XP_006237708.1; XM_006237646.2.
DR   RefSeq; XP_008761654.1; XM_008763432.1.
DR   RefSeq; XP_017448393.1; XM_017592904.1.
DR   RefSeq; XP_017448394.1; XM_017592905.1.
DR   AlphaFoldDB; O88397; -.
DR   SMR; O88397; -.
DR   STRING; 10116.ENSRNOP00000048288; -.
DR   ChEMBL; CHEMBL2073692; -.
DR   TCDB; 2.A.60.1.3; the organo anion transporter (oat) family.
DR   GlyCosmos; O88397; 4 sites, No reported glycans.
DR   GlyGen; O88397; 4 sites.
DR   PhosphoSitePlus; O88397; -.
DR   PaxDb; 10116-ENSRNOP00000048288; -.
DR   Ensembl; ENSRNOT00055017603; ENSRNOP00055014168; ENSRNOG00055010368.
DR   Ensembl; ENSRNOT00060014791; ENSRNOP00060011443; ENSRNOG00060008757.
DR   Ensembl; ENSRNOT00065008537; ENSRNOP00065006020; ENSRNOG00065005666.
DR   GeneID; 80900; -.
DR   KEGG; rno:80900; -.
DR   UCSC; RGD:70985; rat.
DR   AGR; RGD:70985; -.
DR   CTD; 108096; -.
DR   RGD; 70985; Slco1a5.
DR   VEuPathDB; HostDB:ENSRNOG00000047493; -.
DR   eggNOG; KOG3626; Eukaryota.
DR   HOGENOM; CLU_008954_4_0_1; -.
DR   InParanoid; O88397; -.
DR   OrthoDB; 2874223at2759; -.
DR   PhylomeDB; O88397; -.
DR   TreeFam; TF317540; -.
DR   PRO; PR:O88397; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000031249; Expressed in lung and 6 other cell types or tissues.
DR   GO; GO:0009925; C:basal plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IBA:GO_Central.
DR   GO; GO:0031526; C:brush border membrane; IDA:RGD.
DR   GO; GO:0015125; F:bile acid transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0008028; F:monocarboxylic acid transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0008514; F:organic anion transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015349; F:thyroid hormone transmembrane transporter activity; IDA:RGD.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0015721; P:bile acid and bile salt transport; IDA:RGD.
DR   GO; GO:0050892; P:intestinal absorption; IMP:RGD.
DR   GO; GO:0006811; P:monoatomic ion transport; IEA:UniProtKB-KW.
DR   GO; GO:0015718; P:monocarboxylic acid transport; IMP:RGD.
DR   GO; GO:0015711; P:organic anion transport; IDA:RGD.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; IBA:GO_Central.
DR   Gene3D; 1.20.1250.20; MFS general substrate transporter like domains; 1.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR036058; Kazal_dom_sf.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   InterPro; IPR004156; OATP.
DR   NCBIfam; TIGR00805; oat; 1.
DR   PANTHER; PTHR11388; ORGANIC ANION TRANSPORTER; 1.
DR   PANTHER; PTHR11388:SF148; SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER-RELATED; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF03137; OATP; 1.
DR   SUPFAM; SSF100895; Kazal-type serine protease inhibitors; 1.
DR   SUPFAM; SSF103473; MFS general substrate transporter; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Ion transport;
KW   Lipid transport; Membrane; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..670
FT                   /note="Solute carrier organic anion transporter family
FT                   member 1A5"
FT                   /id="PRO_0000191044"
FT   TOPO_DOM        1..20
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        21..40
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        41..59
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        60..80
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        81..86
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        87..111
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        112..155
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        156..184
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        185..203
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        204..224
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        225..242
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        243..267
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        268..311
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        312..333
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        334..353
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        354..377
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        378..381
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        382..405
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        406..513
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        514..536
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        537..545
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        546..571
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        572..605
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        606..623
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        624..670
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          433..488
FT                   /note="Kazal-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   CARBOHYD        124
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        483
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        492
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        439..469
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        445..465
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   DISULFID        454..486
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00798"
FT   CONFLICT        33
FT                   /note="K -> Q (in Ref. 1; AAC32804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        55
FT                   /note="T -> I (in Ref. 1; AAC32804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        70
FT                   /note="L -> F (in Ref. 1; AAC32804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        421
FT                   /note="S -> L (in Ref. 1; AAC32804)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        543
FT                   /note="E -> K (in Ref. 1; AAC32804)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   670 AA;  74577 MW;  17BA60B86E0B567A CRC64;
     MGETEKRVAT HEVRCFSKIK MFLLALTWAY VSKSLSGIYM NTMLTQIERQ FDIPTSIVGF
     INGSFEIGNL LLIIFVSYFG TKLHRPIMIG VGCVIMGLGC FLMSLPHFLM GRYEYETTIS
     PTSNLSSNSF LCMENRSQTL KPTQDPAECI KEMKSLMWIY VLVGNIIRGI GETPIMPLGI
     SYIEDFAKSE NSPLYIGILE TGKVFGPIVG LLLGSFCASI YVDTGSVNTD DLTITPTDTR
     WVGAWWIGFL ICAGVNILSS IPFFFFPKTL PKEGLQDDVD GTNNDKEEKH REKAKEENRG
     ITKDFLPFMK SLSCNPIYML LILTSVLQIN AFINMFTFLP KYLEQQYGKS TAEVVLLIGV
     YNLPPICIGY LLIGFIMKKF KITVKKAAYM AFCLSLFEYL LYFLHFMITC DNFPVAGLTA
     SYEGVHHPLY VENKVLADCN RGCSCSTNSW DPVCGDNGLA YMSACLAGCK KSVGTGTNMV
     FQNCSCIRSS GNSSAVLGLC KKGPECANKL QYFLIMSVIG SFIYSITAIP GYMVLLRCIK
     PEEKSLGIGL HAFCTRVFAG IPAPIYFGAL IDRTCLHWGT LKCGEPGACR MYNINNFRRI
     YLVLPAALRG SSYLPALFIL ILMRKFQFPG EIDSSETELA EMKITVKKSE CTDVHGSPQV
     ENDGELKTRL
//
